Showing results (41-50 of 146) with videos related to
Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2011
Osteopontin modulates the generation of memory CD8+ T cells during influenza virus infectionJunko Morimoto, Kayoko Sato, Yosuke Nakayama, et al.Transplantation|December 16, 2004
Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft antibody suppression induces long-term acceptance of cardiac xenograftsNan Hua, Kenichiro Yamashita, Taku Hashimoto, et al.Biochemical and Biophysical Research Communications|October 27, 2004
Molecular dynamics of STAT3 on IL-6 signaling pathway in living cellsKenji Watanabe, Kenta Saito, Masataka Kinjo, et al.International Immunopharmacology|September 1, 2007
Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibodyNobuchika Yamamoto, Toshihiro Nakashima, Masaharu Torikai, et al.Cytokine|May 3, 2005
Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosisShin-Ichiro Inomata, Noriharu Shijubo, Shigeyuki Kon, et al.Antimicrobial Agents and Chemotherapy|March 21, 2012
Quinolone-induced upregulation of osteopontin gene promoter activity in human lung epithelial cell line A549Beata Shiratori, Jing Zhang, Osamu Usami, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
Critical role of inducible costimulator signaling in the development of arteriosclerosisHisanori Kosuge, Jun-ichi Suzuki, Go Haraguchi, et al.Journal of Medical and Dental Sciences|August 25, 2009
Suppression of neointimal hyperplasia after vascular injury by blocking 4-1BB/4-1BB ligand pathwayAkiyo Karube, Jun-ichi Suzuki, Go Haraguchi, et al.Transplantation|April 30, 2003
Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathwayHisanori Kosuge, Jun-Ichi Suzuki, Ryo Gotoh, et al.Virology|March 16, 2004
Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediatorEtsuro Ono, Saori Yoshino, Keiko Amagai, et al.Pageof 15